Clinical Research Directory

Study of AT-587 in Healthy Subjects

Sponsor: Atea Pharmaceuticals, Inc.

Summary

This study will assess the safety, tolerability and pharmacokinetics (PK) of AT-587 in healthy subjects

Official title: A Phase 1, First-in-Human (FIH), Single-center, Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics (PK) of AT-587 in Healthy Adult Participants

Key Details

Conditions

Interventions

Locations (1)